elevate health glp 1 We offer GLP-1 medical weight loss therapy designed to support sustainable weight management. Your treatment plan is customized based on your history and goals. Call (484) 459-8520 or visit elevatehealthaesthetics.com to Weight Management Support Powered by Peptide GLP GLP-1 Elevate®

Absolute contraindications to GLP-1 receptor agonists include: Personal history of medullary thyroid carcinoma Family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Pregnancy (for weight management indications) Severe gastrointestinal disease, including gastroparesis Patients should be specifically questioned about these conditions during pre-treatment evaluation

When caloric intake drops significantly, it activates survival mechanisms that break down both fat and lean tissue for energy

It's not a reason to panic or stop treatment

The main risks are a temporary resurgence of GI side effects (nausea, constipation, diarrhea), temporary appetite suppression reduction during the low-dose titration phase, and a short-term weight loss pause as tirzepatide builds toward therapeutic levels

Food and Drug Administration (FDA) to treat individuals with type 2 diabetes mellitus and obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one other weight-related medical condition

Your Precision Peptide Genetic Test results show how your body responds to GLP-1 pathways, which may inform your anesthesia team about your medication metabolism and response profile